These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25735385)

  • 1. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Liu XY
    Asian Pac J Cancer Prev; 2015; 16(3):933-9. PubMed ID: 25735385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
    Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
    Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
    Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
    BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
    Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
    J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Preoperative Serum Levels of CA 125 on Epithelial Ovarian Cancer Survival.
    Pradjatmo H; Pradjatmo H
    Asian Pac J Cancer Prev; 2016; 17(4):1881-6. PubMed ID: 27221870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.
    So KA; Hong JH; Jin HM; Kim JW; Song JY; Lee JK; Lee NW
    Gynecol Oncol; 2014 Mar; 132(3):551-5. PubMed ID: 24440470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC).
    Younes G; Segev Y; Begal J; Auslender R; Goldberg Y; Amit A; Lavie O
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():16-20. PubMed ID: 26894377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.
    Okunade KS; Dawodu O; Adenekan M; Nwogu CM; Awofeso O; Ugwu AO; Salako O; John-Olabode S; Olowoselu OF; Anorlu RI
    Niger J Clin Pract; 2020 Aug; 23(8):1141-1147. PubMed ID: 32788493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse.
    Braicu EI; Chekerov R; Richter R; Pop C; Nassir M; Loefgren H; Stamatian F; Muallem MZ; Hall C; Fotopoulou C; Sehouli J; Pietzner K
    Ann Surg Oncol; 2014 Mar; 21(3):955-62. PubMed ID: 24217786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
    Man YN; Wang YN; Hao J; Liu X; Liu C; Zhu C; Wu XZ
    Int J Gynecol Cancer; 2015 Jan; 25(1):24-32. PubMed ID: 25347092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.
    Allensworth SK; Langstraat CL; Martin JR; Lemens MA; McGree ME; Weaver AL; Dowdy SC; Podratz KC; Bakkum-Gamez JN
    Gynecol Oncol; 2013 Sep; 130(3):499-504. PubMed ID: 23747328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
    Li QL; Wang CJ; Qi P; Zhang YX
    Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
    Shen Y; Li L
    Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
    Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.
    Sakurai M; Satoh T; Matsumoto K; Michikami H; Nakamura Y; Nakao S; Ochi H; Onuki M; Minaguchi T; Yoshikawa H
    Int J Gynecol Cancer; 2015 May; 25(4):593-8. PubMed ID: 25756402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
    Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
    J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
    Huang LP; Yu YH; Sheng C; Wang SH
    Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer.
    Nomura H; Tsuda H; Susumu N; Fujii T; Banno K; Kataoka F; Tominaga E; Suzuki A; Chiyoda T; Aoki D
    Int J Gynecol Cancer; 2010 Apr; 20(3):341-5. PubMed ID: 20375794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
    Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
    Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.